by Northwestern University Graphical abstract. Credit: Journal of Clinical Investigation (2023). DOI: 10.1172/JCI161142A new study has revealed that Metixene, an antiparkinsonian drug, has shown remarkable potential as a novel treatment for metastatic breast cancer and brain metastases, providing hope for patients facing this devastating disease. The study was conducted by a team of researchers led by...